Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.
(2016) In BioDrugs- Abstract
- Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8825270
- author
- Calara, Paul S ; Norlin, Jenny M ; Althin, Rikard ; Steen Carlsson, Katarina LU and Schmitt-Egenolf, Marcus
- organization
- publishing date
- 2016-02-16
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BioDrugs
- publisher
- Adis International
- external identifiers
-
- pmid:26883786
- scopus:84958745150
- pmid:26883786
- wos:000376501000008
- ISSN
- 1173-8804
- DOI
- 10.1007/s40259-016-0163-8
- language
- English
- LU publication?
- yes
- id
- 821b3f88-f5d4-481c-adda-f23967279b6e (old id 8825270)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26883786?dopt=Abstract
- date added to LUP
- 2016-04-04 09:39:13
- date last changed
- 2023-09-20 02:53:48
@article{821b3f88-f5d4-481c-adda-f23967279b6e, abstract = {{Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.}}, author = {{Calara, Paul S and Norlin, Jenny M and Althin, Rikard and Steen Carlsson, Katarina and Schmitt-Egenolf, Marcus}}, issn = {{1173-8804}}, language = {{eng}}, month = {{02}}, publisher = {{Adis International}}, series = {{BioDrugs}}, title = {{Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.}}, url = {{http://dx.doi.org/10.1007/s40259-016-0163-8}}, doi = {{10.1007/s40259-016-0163-8}}, year = {{2016}}, }